Pure Global

Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age - Trial NCT06357923

Access comprehensive clinical trial information for NCT06357923 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Nice and is currently Not yet recruiting. The study focuses on Aging. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06357923
Not yet recruiting
diagnostic test
Trial Details
ClinicalTrials.gov • NCT06357923
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age
Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance as Well as Variations and Allelic Mutations in the Main Genes Involved in the Occurrence of Age-related Myelodysplastic Syndromes

Study Focus

Aging

dosage

Interventional

diagnostic test

Sponsor & Location

Centre Hospitalier Universitaire de Nice

Nice, France

Timeline & Enrollment

N/A

May 01, 2024

May 01, 2026

100 participants

Primary Outcome

Expression level of LAMP2 (protein and isoform A and B mRNA)

Summary

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of
 subjects 60 years of age respecting a male/female ratio = 1.

ICD-10 Classifications

Alzheimer disease
Agenesis and underdevelopment of nose
Agenesis of lung
Adult-onset Still disease
Choroidal degeneration

Data Source

ClinicalTrials.gov

NCT06357923

Non-Device Trial